Skip to content

Application of Magnesium Sulfate in General Anesthesia in Maxillofacial Surgery

Application of Magnesium Sulfate in General Anesthesia in Maxillofacial Surgery

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100045981
Enrollment
Unknown
Registered
2021-04-30
Start date
2021-07-01
Completion date
Unknown
Last updated
2022-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental and maxillofacial deformities

Interventions

Control group:Normal saline

Sponsors

Stomatological Hospital of Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 40 years(including 18 years old and 40 years old); 2. ASA I-II level; 3. Body mass index (BMI) is in the range of 18-29; 4. Patients from the same surgical team who are planning to undergo maxillofacial surgery.

Exclusion criteria

Exclusion criteria: 1. Liver and kidney dysfunction diseases, cardiovascular and cerebrovascular diseases, coagulation dysfunction, neuromuscular disease; 2. Chronic pain status, history of opioid or analgesic drug abuse, drug abuse, long-term use of calcium channel blockers, long-term use of NSAID drugs; 3. Hypermagnesemia, basal metabolic diseases, mental diseases, atrioventricular block.

Design outcomes

Primary

MeasureTime frame
Remifentanil requirements;

Secondary

MeasureTime frame
Postoperative pain;Postoperative nausea and vomiting;Serum magnesium ion concentration;Serum creatinine;Blood loss;

Countries

China

Contacts

Public ContactHua Xiaoxiao

Stomatological Hospital of Sun Yat-Sen University

huaxx3@mail.sysu.edu.cn+86 13580443776

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 8, 2026